Long Hill Capital Management (LHC), a Shangai, China-based venture capital firm, closed its inaugural fund, at $125M.
Managed by Xiaodong Jiang and Bo Jiang, who since 2005 have led the China investing practice for New Enterprise Associates (NEA), a global investment firm with over $17 billion in committed capital, Long Hill Capital Venture Partners 1 will invest in early stage technology-enabled healthcare and consumer services companies based in China.
In conjunction with the launch of Long Hill Capital, NEA became an investor in the fund, along with Asia Alternatives and International Finance Corporation (IFC).
Xiaodong and Bo Jiang are joined by an experienced team of investment and operations professionals from such firms as Matrix Partners China and Morningside VC.
Together, the Long Hill Capital team have over 30 years of China venture capital experience and over 15 years of senior operating experience at some of China’s most successful technology and healthcare companies including Alibaba, Huawei and Ping’an Good Doctor. Over the course of their venture capital careers, the team have invested in such industry leading companies as CITIC Pharmaceutical, WeDoctor, Hygeia Medical Services, GST Clinics, LineKong, LianLian Pay, Ele.Me, TheBeastShop and more.